Article
Computational optimization of angiotensin-converting enzyme 2 for SARS-CoV-2 Spike molecular recognition
1 Jan 2021
Abstract excerpt
Since the beginning of the Covid19 pandemic, many efforts have been devoted to identifying approaches to neutralize SARS-CoV-2 replication within the host cell. A promising strategy to block the infection consists of using a mutant of the human receptor angiotensin-converting enzyme 2 (ACE2) as a decoy to compete with endogenous ACE2 for the binding to the SARS-CoV-2 Spike protein, which decreases the ability of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
